Skip to main content

June 10: VDP Formulary, CAD, MCO Search Realignment Now Active

Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2017. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed November 13, 2023.
  2. Facts and Comparisons eAnswers [database online]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2023. Available at: https://fco-factsandcomparisons-com.ezproxy.lib.utexas.edu. Accessed November 13, 2023.
  3. Gabapentin (Neurontin) package insert. Pfizer, July 2022.
  4. Gabapentin extended-release tablets (Gralise) package insert. Almatica Pharma LLC, March 2023.
  5. Gabapentin enacarbil extended-release tablets (Horizant) package insert. Arbor Pharmaceuticals, LLC, August 2022.
  6. The US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res. 1994;18(1):67–73.
  7. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. Gabapentin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2000;(3):CD001415.
  8. Ortega E. Postherpetic neuralgia. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Accessed on December 13, 2023.)
  9. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):CD007938. Published 2017 Jun 9. doi:10.1002/14651858.CD007938.pub4.